ligand
C5 Lenalidomide
Quality Level
assay
≥95%
form
powder or crystals
reaction suitability
reactivity: carboxyl reactive, reagent type: ligand-linker conjugate
functional group
amine
storage temp.
2-8°C
SMILES string
O=C1N(C2CCC(NC2=O)=O)CC3=CC(NC(COCCOCCOCCOCCOCCOCCCCCCN)=O)=CC=C31.Cl
InChI
1S/C31H48N4O10.ClH/c32-9-3-1-2-4-10-40-11-12-41-13-14-42-15-16-43-17-18-44-19-20-45-23-29(37)33-25-5-6-26-24(21-25)22-35(31(26)39)27-7-8-28(36)34-30(27)38;/h5-6,21,27H,1-4,7-20,22-23,32H2,(H,33,37)(H,34,36,38);1H
InChI key
GDNQKCBPUXQOGD-UHFFFAOYSA-N
Application
Protein degrader builiding block C5 Lenalidomide-PEG6-Butyl NH2 hydrochloride enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology. This conjugate contains a Cereblon (CRBN)-recruiting ligand with alternative exit vector, a PEGylated linker, and a pendant amine for reactivity with a carboxylic acid on the target ligand. Because even slight alterations in ligands and crosslinkers can affect ternary complex formation between the target, E3 ligase, and PROTAC, many analogs are prepared to screen for optimal target degradation. When used with other protein degrader building blocks with a terminal amine, parallel synthesis can be used to more quickly generate PROTAC libraries that feature variation in crosslinker length, composition, and E3 ligase ligand.
Technology Spotlight:Degrader Building Blocks for Targeted Protein Degradation
Portal:Building PROTAC® Degraders for Targeted Protein Degradation
Technology Spotlight:Degrader Building Blocks for Targeted Protein Degradation
Portal:Building PROTAC® Degraders for Targeted Protein Degradation
Other Notes
Legal Information
PROTAC is a registered trademark of Arvinas Operations, Inc., and is used under license
저장 등급
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
문서
Protein Degrader Building Blocks are a collection of crosslinker-E3 ligand conjugates with a pendant functional group for covalent linkage to a target ligand.
Daniel P Bondeson et al.
Annual review of pharmacology and toxicology, 57, 107-123 (2016-10-13)
Protein homeostasis networks are highly regulated systems responsible for maintaining the health and productivity of cells. Whereas therapeutics have been developed to disrupt protein homeostasis, more recently identified techniques have been used to repurpose homeostatic networks to effect degradation of
국제 무역 품목 번호
| SKU | GTIN |
|---|---|
| 921327-50MG | 04065266431841 |